Matthew L. Sherman
2014 - Acceleron Pharma
In 2014, Matthew L. Sherman earned a total compensation of $531.7K as Executive Vice President and Chief Medical Officer at Acceleron Pharma, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $137,200 |
|---|---|
| Salary | $392,000 |
| Other | $2,500 |
| Total | $531,700 |
Sherman received $392K in salary, accounting for 74% of the total pay in 2014.
Sherman also received $137.2K in non-equity incentive plan and $2.5K in other compensation.
Rankings
In 2014, Matthew L. Sherman's compensation ranked 10,073rd out of 13,032 executives tracked by ExecPay. In other words, Sherman earned more than 22.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,073 out of 13,032 | 23rd |
Division Manufacturing | 3,828 out of 4,965 | 23rd |
Major group Chemicals And Allied Products | 1,315 out of 1,690 | 22nd |
Industry group Drugs | 1,051 out of 1,369 | 23rd |
Industry Biological Products, Except Diagnostic Substances | 193 out of 241 | 20th |
Source: SEC filing on April 15, 2016.
Sherman's colleagues
We found four more compensation records of executives who worked with Matthew L. Sherman at Acceleron Pharma in 2014.